This article is brought to you by Our Lady of the Angels. An innovative non-invasive technology at Our Lady of the Angels is helping doctors better detect liver problems, leading to earlier treatment ...

This milestone opens a path for FibroScan ® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development WESTBOROUGH, Mass., Sept. 8, 2025 ...

PARIS--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, announces the launch of FibroScan 630 Expert, a high-performance elastography engine that ...

WALTHAM, Mass. & FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Echosens North America, a high-technology company offering the FibroScan ® portfolio of solutions, and ChronWell, a digital health and ...

MUSKEGON, Mich. -- It's known to many as the silent epidemic - a viral infection that spreads through blood contact and affects an estimated 3.5 million people nationwide. According to experts, half ...

The Fibroscan test is recognized in the medical community as an established procedure to assess liver fibrosis. It received FDA approval in 2012. A simple probe is placed on the skin in between the ...

Experts say about one in 10 Americans have some form of liver disease like hepatitis, cirrhosis or cancer.Many of those patients would have to undergo a core needle biopsy procedure, which is invasive ...

PHILADELPHIA — FibroScan screening for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis could significantly improve patient diagnosis and care, as data presented at the American ...

Liver fibrosis happens when persistent inflammation of the liver causes excessive scar tissue to build up in the organ and nearby blood vessels. The presence of scar tissue can impair overall liver ...

Echosens, the company behind the industry-leading FibroScan technology, is introducing FibroScan 630 Expert, a unique device that drives non-invasive liver disease ...